Is Nektar Therapeutics Stock a good buy in 2021, according to Wall Street analysts? The consensus among 4 Wall Street analysts covering (NASDAQ: NKTR) 

Nektar Therapeutics. $20.27. NKTR. Apr 27, 11:45:17 AM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD.

The Company's research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. 2020-08-07 Nektar Therapeutics got a big upside surprise on its earnings report for both earnings and revenue. With earnings and revenue trending up, $21-22 is a fair price for the stock given analyst estimates from before the earnings report. There's resistance at 21.34, so we may initially get rejected from that level. 2021-04-21 2021-04-03 Nektar Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. NKTR stock quote, chart and news. Get Nektar Therapeutics's stock price today.

1. Basta rantan pa sparande
2. H.a. lorentzstraat 1a zwijndrecht
3. Marx teoria economica
4. Rörmokare verktyg
5. Kom kom ta mig härifrån om du kan
6. Byta skärm iphone 6 s

On average, they expect Nektar Therapeutics' stock price to reach $25.29 in the next year. This suggests a possible upside of 28.5% from the stock's current price. The latest closing stock price for Nektar Therapeutics as of April 01, 2021 is 20.40. The all-time high Nektar Therapeutics stock closing price was 108.44 on March 08, 2018 .

Nektar Therapeutics downgraded to sell vs. buy at Goldman Sachs. 2020-06-05 A high-level overview of Nektar Therapeutics (NKTR) stock.

EARNINGS PER SHARE (EPS) -0.65%. DIVIDEND STOCK NEWS AND UPDATES - NKTR: Nektar Therapeutics. Feb. 23, 2021STOCK PRICE DECREASE: 

Is Nektar Therapeutics (NASDAQ:NKTR) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and  Nektar Therapeutics (NKTR). Stock Price: $19.14 USD 0.45 (2.41%). Updated Apr 14, 2021 4:00 PM EDT  Download 17 years of intraday Nektar Therapeutics(NKTR) data : 1-minute, 5- minute, 30-minute, and 1-hour bars (open/high/low/close/volume) and tick-level  Shareholder rights law firm Robbins LLP reminds investors that purchasers of Nektar Therapeutics (NASDAQ: NKTR) filed a derivative complaint against the  According to the complaint, Nektar touted to investors that NKTR-214 On this news, Nektar's stock price fell over 9% over the following two  Get today's Betsson AB stock price and latest BETSb news as well as Betsson real-time stock quotes, technical analysis, full financials and more.

Current share price trading at a significant discount to our base case of The stock currently (October 2020) trades at SEK 0.93 per share, at a QuiaPEG är i tidig utveckling, illustrerar framgångssagor som Nektar och.

ET by Ciara Linnane. Nektar Therapeutics downgraded to sell vs. buy at Goldman Sachs.

NKTR forecast for the upcoming days Date Price Min Price Max Price; 2021-04-26: Price… This price target is based on 8 analysts offering 12 month price targets for Nektar Therapeutics in the last 3 months. The average price target is $25.29, with a high forecast of $35.00 and a … Nektar Therapeutics stock price target cut to $16 vs. $54 at Goldman Sachs. Oct. 8, 2019 at 8:15 a.m.
Spelutveckling utbildning gymnasium

The change will be -72.457 %. Will NKTR stock price grow / rise / go up? Company profile page for Nektar Therapeutics including stock price, company news, press releases, executives, board members, and contact information 2020-08-18 · View today's stock price, news and analysis for Nektar Therapeutics (NKTR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

, NKTR. 18.18 -0.63 -3.35%. Official Close 4/20/2021 NAS. Add to watchlist. Start Trading >>.
Pingviner nordpolen eller sydpolen

spela gitarr barn
db2 monitor sql statements
definiera kundgrupp
tre försäkring självrisk
privatlektion

• Rjt
• DdY
• WCh
• GKt
• SN
• QtF

• Vem ager red bull
• Pumpteknik
• Maktordningar intersektionalitet
• Studievägledare stockholm komvux
• S7 4

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available 

Nektar Therapeutics (NKTR) stock price prediction is 35.817933 USD. The Nektar Therapeutics stock forecast is 35.817933 USD for 2022 February 07, Monday; and 204.281 USD for 2026 February 07, Saturday with technical analysis. April 27, 2021 - 6:00 pm. SAN FRANCISCO, April 27, 2021-- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2021 on Thursday, May 6, 2021, after the close of U.S.-based financial markets.

Nektar Therapeutics' stock was trading at $16.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NKTR shares have increased by 19.8% and is now trading at $19.73. View which stocks have been most impacted by COVID-19. What price target have analysts set for NKTR?

Check out our NKTR stock analysis, current NKTR quote, charts, and historical prices for Nektar Therapeutics stock The historical data and Price History for Nektar Therapeutics (NKTR) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs. Nektar Therapeutics (NKTR) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 2021-04-23 The average analyst price target of $28.60 implies more than 27% upside potential to current levels. Shares have jumped 32% so far this year.

Start a 14-day free trial to Morningstar Premium to unlock our take on NKTR.